APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transcriptomics

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

Selected research

Market Analysis & Forecast

Global Transcriptomics Market Analysis and Forecast 2026-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchTranscriptomics Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Transcriptomics Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Transcriptomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transcriptomics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transcriptomics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Transcriptomics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transcriptomics, also provides the revenue of main regions and countries. Of the upcoming market potential for Transcriptomics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transcriptomics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transcriptomics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Transcriptomics revenue, projected growth trends, production technology, application and end-user industry.

Transcriptomics Segment by Company

Thermo Fisher Scientific

Illumina

QIAGEN (Exiqon)

Agilent Technologies

Roche

GE Healthcare

Bio-Rad Laboratories

Fluidigm

Transcriptomics Segment by Type

PCR

Microarray

Sequencing

Transcriptomics Segment by Application

Pharmaceutical and Biotechnology

Academic Research and Government Institutes

Hospitals and Diagnostic Centers

Transcriptomics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcriptomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transcriptomics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcriptomics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transcriptomics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transcriptomics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptomics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transcriptomics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PCR Major Player Table 3. Microarray Major Player Table 4. Sequencing Major Player Table 5. Global Transcriptomics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical and Biotechnology Major Player Table 7. Academic Research and Government Institutes Major Player Table 8. Hospitals and Diagnostic Centers Major Player Table 9. Transcriptomics Industry Trends Table 10. Transcriptomics Industry Drivers Table 11. Transcriptomics Industry Opportunities and Challenges Table 12. Transcriptomics Industry Restraints Table 13. Global Transcriptomics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Transcriptomics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Transcriptomics Market Share by Region (2021-2026) Table 16. Global Transcriptomics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Transcriptomics Market Share by Region (2027-2032) Table 18. Global Transcriptomics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Transcriptomics Revenue Market Share by Players (2021-2026) Table 20. Global Transcriptomics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Transcriptomics Key Players Headquarters & Area Served Table 22. Global Transcriptomics Players, Product Type & Application Table 23. Global Transcriptomics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Transcriptomics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Transcriptomics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Transcriptomics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Transcriptomics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Transcriptomics Revenue Market Share by Type (2021-2026) Table 30. Global Transcriptomics Revenue Market Share by Type (2027-2032) Table 31. Global Transcriptomics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Transcriptomics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Transcriptomics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Transcriptomics Revenue Market Share by Application (2021-2026) Table 35. Global Transcriptomics Revenue Market Share by Application (2027-2032) Table 36. Thermo Fisher Scientific Company Information Table 37. Thermo Fisher Scientific Business Overview Table 38. Thermo Fisher Scientific Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Thermo Fisher Scientific Transcriptomics Product Portfolio Table 40. Thermo Fisher Scientific Recent Development Table 41. Illumina Company Information Table 42. Illumina Business Overview Table 43. Illumina Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Illumina Transcriptomics Product Portfolio Table 45. Illumina Recent Development Table 46. QIAGEN (Exiqon) Company Information Table 47. QIAGEN (Exiqon) Business Overview Table 48. QIAGEN (Exiqon) Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. QIAGEN (Exiqon) Transcriptomics Product Portfolio Table 50. QIAGEN (Exiqon) Recent Development Table 51. Agilent Technologies Company Information Table 52. Agilent Technologies Business Overview Table 53. Agilent Technologies Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Agilent Technologies Transcriptomics Product Portfolio Table 55. Agilent Technologies Recent Development Table 56. Roche Company Information Table 57. Roche Business Overview Table 58. Roche Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Roche Transcriptomics Product Portfolio Table 60. Roche Recent Development Table 61. GE Healthcare Company Information Table 62. GE Healthcare Business Overview Table 63. GE Healthcare Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. GE Healthcare Transcriptomics Product Portfolio Table 65. GE Healthcare Recent Development Table 66. Bio-Rad Laboratories Company Information Table 67. Bio-Rad Laboratories Business Overview Table 68. Bio-Rad Laboratories Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Bio-Rad Laboratories Transcriptomics Product Portfolio Table 70. Bio-Rad Laboratories Recent Development Table 71. Fluidigm Company Information Table 72. Fluidigm Business Overview Table 73. Fluidigm Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Fluidigm Transcriptomics Product Portfolio Table 75. Fluidigm Recent Development Table 76. North America Transcriptomics Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Transcriptomics Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Transcriptomics Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Transcriptomics Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Transcriptomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Transcriptomics Revenue by Country (2021-2026) & (US$ Million) Table 82. North America Transcriptomics Revenue by Country (US$ Million) & (2027-2032) Table 83. Europe Transcriptomics Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Transcriptomics Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Transcriptomics Revenue by Application (2021-2026) & (US$ Million) Table 86. Europe Transcriptomics Revenue by Application (2027-2032) & (US$ Million) Table 87. Europe Transcriptomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Transcriptomics Revenue by Country (2021-2026) & (US$ Million) Table 89. Europe Transcriptomics Revenue by Country (US$ Million) & (2027-2032) Table 90. China Transcriptomics Revenue by Type (2021-2026) & (US$ Million) Table 91. China Transcriptomics Revenue by Type (2027-2032) & (US$ Million) Table 92. China Transcriptomics Revenue by Application (2021-2026) & (US$ Million) Table 93. China Transcriptomics Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Transcriptomics Revenue by Type (2021-2026) & (US$ Million) Table 95. Asia Transcriptomics Revenue by Type (2027-2032) & (US$ Million) Table 96. Asia Transcriptomics Revenue by Application (2021-2026) & (US$ Million) Table 97. Asia Transcriptomics Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Transcriptomics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Transcriptomics Revenue by Region (US$ Million) & (2021-2026) Table 100. Asia Transcriptomics Revenue by Region (US$ Million) & (2027-2032) Table 101. SAMEA Transcriptomics Revenue by Type (2021-2026) & (US$ Million) Table 102. SAMEA Transcriptomics Revenue by Type (2027-2032) & (US$ Million) Table 103. SAMEA Transcriptomics Revenue by Application (2021-2026) & (US$ Million) Table 104. SAMEA Transcriptomics Revenue by Application (2027-2032) & (US$ Million) Table 105. SAMEA Transcriptomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. SAMEA Transcriptomics Revenue by Country (2021-2026) & (US$ Million) Table 107. SAMEA Transcriptomics Revenue by Country (US$ Million) & (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Transcriptomics Image Figure 2. Global Transcriptomics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transcriptomics Market Size Share 2021 VS 2025 VS 2032 Figure 4. PCR Image Figure 5. Microarray Image Figure 6. Sequencing Image Figure 7. Global Transcriptomics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Transcriptomics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical and Biotechnology Image Figure 10. Academic Research and Government Institutes Image Figure 11. Hospitals and Diagnostic Centers Image Figure 12. Global Transcriptomics Market Size (US$ Million) & (2021-2032) Figure 13. Global Transcriptomics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Transcriptomics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Transcriptomics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Transcriptomics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Transcriptomics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Transcriptomics Revenue Market Share by Type (2021-2032) Figure 20. Global Transcriptomics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Transcriptomics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Transcriptomics Revenue Market Share by Application (2021-2032) Figure 23. North America Transcriptomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Transcriptomics Revenue Share by Type (2021-2032) Figure 25. North America Transcriptomics Revenue Share by Application (2021-2032) Figure 26. North America Transcriptomics Revenue Share by Country (2021-2032) Figure 27. United States Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Transcriptomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Transcriptomics Revenue Share by Type (2021-2032) Figure 32. Europe Transcriptomics Revenue Share by Application (2021-2032) Figure 33. Europe Transcriptomics Revenue Share by Country (2021-2032) Figure 34. Germany Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Transcriptomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Transcriptomics Revenue Share by Type (2021-2032) Figure 44. China Transcriptomics Revenue Share by Application (2021-2032) Figure 45. Asia Transcriptomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Transcriptomics Revenue Share by Type (2021-2032) Figure 47. Asia Transcriptomics Revenue Share by Application (2021-2032) Figure 48. Asia Transcriptomics Revenue Share by Region (2021-2032) Figure 49. Japan Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Transcriptomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Transcriptomics Revenue Share by Type (2021-2032) Figure 57. SAMEA Transcriptomics Revenue Share by Application (2021-2032) Figure 58. SAMEA Transcriptomics Revenue Share by Country (2021-2032) Figure 59. Brazil Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Transcriptomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • PCR
  • Microarray
  • Sequencing
Applications
  • Pharmaceutical and Biotechnology
  • Academic Research and Government Institutes
  • Hospitals and Diagnostic Centers
Companies covered
  • Thermo Fisher Scientific
  • Illumina
  • QIAGEN (Exiqon)
  • Agilent Technologies
  • Roche
  • GE Healthcare
  • Bio-Rad Laboratories
  • Fluidigm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transcriptomics Market by Type
  3. 1.2.1 Global Transcriptomics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PCR
  5. 1.2.3 Microarray
  6. 1.2.4 Sequencing
  7. 1.3 Transcriptomics Market by Application
  8. 1.3.1 Global Transcriptomics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical and Biotechnology
  10. 1.3.3 Academic Research and Government Institutes
  11. 1.3.4 Hospitals and Diagnostic Centers
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Transcriptomics Market Dynamics
  1. 2.1 Transcriptomics Industry Trends
  2. 2.2 Transcriptomics Industry Drivers
  3. 2.3 Transcriptomics Industry Opportunities and Challenges
  4. 2.4 Transcriptomics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Transcriptomics Market Perspective (2021-2032)
  2. 3.2 Global Transcriptomics Growth Trends by Region
  3. 3.2.1 Global Transcriptomics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transcriptomics Market Size by Region (2021-2026)
  5. 3.2.3 Global Transcriptomics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Transcriptomics Revenue by Players
  2. 4.1.1 Global Transcriptomics Revenue by Players (2021-2026)
  3. 4.1.2 Global Transcriptomics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Transcriptomics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transcriptomics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Transcriptomics Key Players Headquarters & Area Served
  7. 4.4 Global Transcriptomics Players, Product Type & Application
  8. 4.5 Global Transcriptomics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Transcriptomics Market CR5 and HHI
  11. 4.6.3 2025 Transcriptomics Tier 1, Tier 2, and Tier 3
5 Transcriptomics Market Size by Type
  1. 5.1 Global Transcriptomics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Transcriptomics Revenue by Type (2021-2032)
  3. 5.3 Global Transcriptomics Revenue Market Share by Type (2021-2032)
6 Transcriptomics Market Size by Application
  1. 6.1 Global Transcriptomics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Transcriptomics Revenue by Application (2021-2032)
  3. 6.3 Global Transcriptomics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Transcriptomics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Transcriptomics Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Illumina
  8. 7.2.1 Illumina Company Information
  9. 7.2.2 Illumina Business Overview
  10. 7.2.3 Illumina Transcriptomics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Illumina Transcriptomics Product Portfolio
  12. 7.2.5 Illumina Recent Developments
  13. 7.3 QIAGEN (Exiqon)
  14. 7.3.1 QIAGEN (Exiqon) Company Information
  15. 7.3.2 QIAGEN (Exiqon) Business Overview
  16. 7.3.3 QIAGEN (Exiqon) Transcriptomics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 QIAGEN (Exiqon) Transcriptomics Product Portfolio
  18. 7.3.5 QIAGEN (Exiqon) Recent Developments
  19. 7.4 Agilent Technologies
  20. 7.4.1 Agilent Technologies Company Information
  21. 7.4.2 Agilent Technologies Business Overview
  22. 7.4.3 Agilent Technologies Transcriptomics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Agilent Technologies Transcriptomics Product Portfolio
  24. 7.4.5 Agilent Technologies Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Transcriptomics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Transcriptomics Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 GE Healthcare
  32. 7.6.1 GE Healthcare Company Information
  33. 7.6.2 GE Healthcare Business Overview
  34. 7.6.3 GE Healthcare Transcriptomics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GE Healthcare Transcriptomics Product Portfolio
  36. 7.6.5 GE Healthcare Recent Developments
  37. 7.7 Bio-Rad Laboratories
  38. 7.7.1 Bio-Rad Laboratories Company Information
  39. 7.7.2 Bio-Rad Laboratories Business Overview
  40. 7.7.3 Bio-Rad Laboratories Transcriptomics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad Laboratories Transcriptomics Product Portfolio
  42. 7.7.5 Bio-Rad Laboratories Recent Developments
  43. 7.8 Fluidigm
  44. 7.8.1 Fluidigm Company Information
  45. 7.8.2 Fluidigm Business Overview
  46. 7.8.3 Fluidigm Transcriptomics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Fluidigm Transcriptomics Product Portfolio
  48. 7.8.5 Fluidigm Recent Developments
8 North America
  1. 8.1 North America Transcriptomics Revenue (2021-2032)
  2. 8.2 North America Transcriptomics Revenue by Type (2021-2032)
  3. 8.2.1 North America Transcriptomics Revenue by Type (2021-2026)
  4. 8.2.2 North America Transcriptomics Revenue by Type (2027-2032)
  5. 8.3 North America Transcriptomics Revenue Share by Type (2021-2032)
  6. 8.4 North America Transcriptomics Revenue by Application (2021-2032)
  7. 8.4.1 North America Transcriptomics Revenue by Application (2021-2026)
  8. 8.4.2 North America Transcriptomics Revenue by Application (2027-2032)
  9. 8.5 North America Transcriptomics Revenue Share by Application (2021-2032)
  10. 8.6 North America Transcriptomics Revenue by Country
  11. 8.6.1 North America Transcriptomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Transcriptomics Revenue by Country (2021-2026)
  13. 8.6.3 North America Transcriptomics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Transcriptomics Revenue (2021-2032)
  2. 9.2 Europe Transcriptomics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Transcriptomics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Transcriptomics Revenue by Type (2027-2032)
  5. 9.3 Europe Transcriptomics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Transcriptomics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Transcriptomics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Transcriptomics Revenue by Application (2027-2032)
  9. 9.5 Europe Transcriptomics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Transcriptomics Revenue by Country
  11. 9.6.1 Europe Transcriptomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Transcriptomics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Transcriptomics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Transcriptomics Revenue (2021-2032)
  2. 10.2 China Transcriptomics Revenue by Type (2021-2032)
  3. 10.2.1 China Transcriptomics Revenue by Type (2021-2026)
  4. 10.2.2 China Transcriptomics Revenue by Type (2027-2032)
  5. 10.3 China Transcriptomics Revenue Share by Type (2021-2032)
  6. 10.4 China Transcriptomics Revenue by Application (2021-2032)
  7. 10.4.1 China Transcriptomics Revenue by Application (2021-2026)
  8. 10.4.2 China Transcriptomics Revenue by Application (2027-2032)
  9. 10.5 China Transcriptomics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transcriptomics Revenue (2021-2032)
  2. 11.2 Asia Transcriptomics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Transcriptomics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Transcriptomics Revenue by Type (2027-2032)
  5. 11.3 Asia Transcriptomics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Transcriptomics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Transcriptomics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Transcriptomics Revenue by Application (2027-2032)
  9. 11.5 Asia Transcriptomics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Transcriptomics Revenue by Country
  11. 11.6.1 Asia Transcriptomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Transcriptomics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Transcriptomics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transcriptomics Revenue (2021-2032)
  2. 12.2 SAMEA Transcriptomics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Transcriptomics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Transcriptomics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Transcriptomics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Transcriptomics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Transcriptomics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Transcriptomics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Transcriptomics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Transcriptomics Revenue by Country
  11. 12.6.1 SAMEA Transcriptomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Transcriptomics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Transcriptomics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst